Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B7 | P56937 | 1/20 | 0.60 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.59 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7529348 | 1.00 | HSD17B7 (0.60) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL13656757 | 1.00 | HSD17B7 (0.60) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL7527383 | 1.00 | HSD17B7 (0.60) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL14561091 | 0.84 | SRD5A1 (0.56) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL7524799 | 0.84 | HSD17B7 (0.57) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL5408042 | 0.84 | SRD5A1 (0.56) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL5427981 | 0.84 | SRD5A1 (0.56) | SRD5A1SRD5A2 | |
| SCHEMBL7524800 | 0.84 | HSD17B7 (0.57) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL5408037 | 0.84 | SRD5A1 (0.56) | HSD17B7SRD5A1SRD5A2 | |
| SCHEMBL10273977 | 0.84 | CYP19A1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0880540-B1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | AVENTIS PHARMA INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6365597-B1 | FOR THERAPY OF ANDROGEN AND ESTROGEN MEDIATED DISORDERS, INCLUDING BENIGN PROSTATIC HYPERPLASIA, ANDROGEN MEDIATED PROSTATE CANCER, ESTROGEN MEDIATED BREAST CANCER AND ACNE | AVENTIS PHARMACEUTICALS INC. | 2002-04-02 | — | — | US | disclosed |
| EP-0705273-B1 | 17-HALOGENO-4-AZAANDROSTENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | RICHTER GEDEON VEGYESZET (HU) | 2002-03-27 | — | — | EP | disclosed |
| EP-0705272-B1 | NOVEL PROCESS FOR PREPARING 17 BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES | RICHTER GEDEON VEGYESZET (HU) | 2002-03-27 | — | — | EP | disclosed |
| EP-0650495-B1 | IMPROVED ANTIANDROGENS | ENDORECHERCHE INC (CA) | 2000-11-08 | — | — | EP | disclosed |
| US-6015806-A | TOPICAL USE IN THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES ASSOCIATED WITH THE SKIN. | ENDORECHERCHE (CA) | 2000-01-18 | — | — | US | disclosed |
| EP-0880540-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0700291-B1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO INC (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997030069-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-21 | — | — | WO | disclosed |
| US-5583138-A | REDUCTASE INHIBITOR; SKIN DISORDERS | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1996-12-10 | — | — | US | disclosed |
| EP-0641211-A1 | INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY | ENDORECHERCHE INC. (CA) | 1995-03-08 | — | — | EP | disclosed |
| WO-1995000532-A1 | 17-HALOGENO-4-AZAANDROSTENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1995-01-05 | — | — | WO | disclosed |
| WO-1995000531-A1 | NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1995-01-05 | — | — | WO | disclosed |
| WO-1994026767-A1 | IMPROVED ANTIANDROGENS | ENDORECHERCHE INC. (CA) | 1994-11-24 | — | — | WO | disclosed |
| US-5359071-A | Selective antagonist of testosterone 5-alpha-reductase 1 | MERCK & CO., INC. (US) | 1994-10-25 | — | — | US | disclosed |
| WO-1993023053-A1 | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY | ENDORECHERCHE INC. (CA) | 1993-11-25 | — | — | WO | disclosed |
| US-5155107-A | Inhibiting androgen action, anticarcinogenic agents, treating skin disorders, baldness | FARMITALIA CARLO ERBA (IT) | 1992-10-13 | — | — | US | disclosed |
| EP-0468012-A1 | 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | ERBA CARLO SPA (IT) | 1992-01-29 | — | — | EP | disclosed |
| WO-1991012261-A1 | 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FARMITALIA CARLO ERBA S.R.L. (IT) | 1991-08-22 | — | — | WO | disclosed |
| US-4377584-A | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors | MERCK & CO., INC. (US) | 1983-03-22 | — | — | US | disclosed |